Search

Your search keyword '"Altintas A."' showing total 284 results

Search Constraints

Start Over You searched for: Author "Altintas A." Remove constraint Author: "Altintas A." Topic internal medicine Remove constraint Topic: internal medicine
284 results on '"Altintas A."'

Search Results

1. BMI is not independently associated with coronary artery calcification in a large single‐center CT cohort

2. Inflammation, Hyperglycemia, and Adverse Outcomes in Individuals With Diabetes Mellitus Hospitalized for COVID-19

3. Understanding potential associations between anatomic and other factors in OSA severity

4. Patients with Vitamin D Deficiency Are at Higher Risk of Developing Calcified and Mixed Plaques

5. Optical coherence tomography measurements in patients with systemic hypertension

6. Deiodinase-3 is a thyrostat to regulate podocyte homeostasis

7. Hypofractionated frameless gamma knife radiosurgery for large metastatic brain tumors

8. Retrospective analyzes of adverse events during biologic agents in children with juvenile idiopathic arthritis from a single center in Turkey

9. Prognostic Value of CDX2 and Villin Expression in Advanced Stage Colorectal Carcinoma

10. Determination of cerebral blood flow velocity and microembolic signals in essential thrombocytosis by transcranial doppler ultrasonography

11. Juvenil idiopatik artritli Türk çocukların büyüme parametreleri

12. Retrospective Analysis of the Factors Affecting Growth Parameters in Turkish Children With Systemic Lupus Erythematosus

13. Clinical findings of patients with cystic fibrosis according to newborn screening results

14. The effectiveness of serum S100B, TRAIL, and adropin levels in predicting clinical outcome, final infarct core, and stroke subtypes of acute ischemic stroke patients

15. 1196 A randomised phase II study of combination chemotherapy with nintedanib/placebo in advanced/recurrent endometrial cancer. FANDANGO/ENGOT-EN1/FANDANGO

16. The evaluation of cTnT/CK-MB ratio is as a predictor of change in cardiac function after myocardial infarction

17. Safety and efficacy of non-steroidal anti-inflammatory drugs to reduce ileus after colorectal surgery

18. Early clinical markers of aggressive multiple sclerosis

19. Redefining the Multiple Sclerosis Severity Score (MSSS): The effect of sex and onset phenotype

20. Clinical and therapeutic predictors of disease outcomes in AQP4-IgG+ neuromyelitis optica spectrum disorder

21. Risk of secondary progressive multiple sclerosis: A longitudinal study

22. Neuroprotective effects of hemicraniectomy in malignant middle cerebral artery infarctions: experimental study

23. suPAR Cut-Offs for Risk Stratification in Patients With Symptoms of COVID-19

24. Dysregulated phenylalanine catabolism plays a key role in the trajectory of cardiac aging

25. Evaluation of the anatomical and electrical axis of the heart after pneumonectomy

26. Disease Severity and Genotype Affect Physical Growth in Children With Familial Mediterranean Fever

27. Evaluation of nutritional status in children with amblyopia

28. Annexin A1 as a potential prognostic biomarker for COVID-19 disease: Case-control study

29. Metabolic Changes in Peripheral Blood Mononuclear Cells Isolated From Patients With End Stage Renal Disease

30. Successful treatment of COVID-19 infection in a patient with tracheostomy

31. Assessment of epicardial adipose tissue thickness and total calcium score in sarcoidosis patients

32. Brain atrophy and lesion burden are associated with disability progression in a multiple sclerosis real-world dataset using only T2-FLAIR: The NeuroSTREAM MSBase study

33. The Turkish experience of COVID-19 infection in people with NMOSD and MOGAD: a milder course?

34. Predictors of survival in turkish patients with primary glioblastoma

35. Clinical Outcomes and Independent Risk Factors for 90-Day Mortality in Critically Ill Patients with Respiratory Failure Infected with SARS-CoV-2: A Multicenter Study in Turkish Intensive Care Units

36. Concealed Coronary Atherosclerosis In Idiopathic Paroxysmal Atrial Fibrillation is Associated with Imminent Cardiovascular Diseases

37. Soluble Urokinase Plasminogen Activator Receptor as a Decision Marker for Early Discharge of Patients with COVID-19 Symptoms in the Emergency Department

38. Response to Re ‘Endovascular Treatment of Chronic and Acute on Chronic Mesenteric Ischaemia: Results From a National Cohort of 245 Cases’

39. A Pilot Comparative Study Between Serological and Genetic Investigations in Relationship to Clinical Outcomes on Patients with Cystic Echinococcosis

40. Immunization status in chronic obstructive pulmonary disease: A multicenter study from Turkey

41. Extracranial Metastasis of IDH-1 Wild Type Glioblastomas

42. Benefits of eculizumab in AQP4+ neuromyelitis optica spectrum disorder: Subgroup analyses of the randomized controlled phase 3 PREVENT trial

43. Relative Fat Mass Index can be solution for obesity paradox in coronary artery disease severity prediction calculated by SYNTAX Score

44. Pericardial fat and its influence on cardiac diastolic function

45. Growth Parameters of Turkish Children With an Autoinflammatory Disease Before and After Canakinumab Treatment

46. Clinical features and accompanying findings of Pseudo-Bartter Syndrome in cystic fibrosis

47. Low levels of the prognostic biomarker suPAR are predictive of mild outcome in patients with symptoms of COVID-19 - a prospective cohort study

48. Caenorhabditis elegans Lipin 1 moderates the lifespan‐shortening effects of dietary glucose by maintaining ω‐6 polyunsaturated fatty acids

49. The use of Modified Rio score for determining treatment failure in patients with multiple sclerosis: retrospective descriptive case series study

50. Endovascular Treatment of Chronic and Acute on Chronic Mesenteric Ischaemia: Results From a National Cohort of 245 Cases

Catalog

Books, media, physical & digital resources